David P. Hochman - Sep 17, 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role: Chief Executive Officer and Chairperson, Director
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Stock symbol: OBIO
Transactions as of: Sep 17, 2025
Transactions value $: -$107,349
Form type: 4
Date filed: 9/19/2025, 05:30 PM
Previous filing: Aug 25, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hochman David P	Chief Executive Officer and Chairperson, Director	C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE	/s/ Andrew Taylor, Attorney-in-Fact	2025-09-19	0001292834

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OBIO	Common Stock, par value $0.0001 per share ("Common Stock")	Tax liability	-$99.3K	-40.4K	-6.19%	$2.46	611K	Sep 17, 2025	Direct	F1
transaction	OBIO	Common Stock	Tax liability	-$8.08K	-3.28K	-0.73%	$2.46	446K	Sep 17, 2025	By the DPH 2008 Trust	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

Remarks:

Chief Executive Officer and Chairperson